The recent progress on nanomaterial-based chemosensors for diagnosis of human exhaled breath: a review
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Advanced Chemical Sensor Technologies · Gas Sensing Nanomaterials and Sensors · Analytical Chemistry and Sensors
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Risby TH, Solga S (2006) Current status of clinical breath analysis. Appl Phys B 85:421–426. https://doi.org/10.1007/s00340-006-2280-410.1007/s00340-006-2280-4 ↗
2. Risby TH, Tittel FK (2010) Current status of midinfrared quantum and interband cascade lasers for clinical breath analysis. Opt Eng 49(11):1–14. https://doi.org/10.1117/1.349876810.1117/1.3498768 ↗
3. Dolch M, Praun S, Villiger J, Choukér A, Schelling G (2020) Breath gas analysis. In: Stress challenges and immunity in space: from mechanisms to monitoring and preventive strategies (pp. 451–461). Springer
4. Kundu SK, Kumagai S, Sasaki M (2013) A wearable capacitive sensor for monitoring human respiratory rate. Jpn J Appl Phys 52(4S), 04CL05. https://doi.org/10.7567/JJAP.52.04CL0510.7567/JJAP.52.04CL05 ↗
5. Tai H, Wang S, Duan Z, Jiang Y (2020) Evolution of breath analysis based on humidity and gas sensors: potential and challenges. Sens Actuators B Chem 318:128104. https://doi.org/10.1016/j.snb.2020.12810410.1016/j.snb.2020.128104 ↗
6. Wielgosz J, Schuyler BS, Lutz A, Davidson RJ (2016) Long-term mindfulness training is associated with reliable differences in resting respiration rate. Sci Rep 6(1):27533. https://doi.org/10.1038/srep2753310.1038/srep27533 ↗
7. Rattray NJ, Hamrang Z, Trivedi DK, Goodacre R, Fowler SJ (2014) Taking your breath away: metabolomics breathes life in to personalized medicine. Trends Biotechnol 32:538–548. https://doi.org/10.1016/j.tibtech.2014.08.00310.1016/j.tibtech.2014.08.003 ↗
8. Hibbard T, Killard AJ (2011) Breath ammonia analysis: clinical application and measurement. Crit Rev Anal Chem 41:21–35. https://doi.org/10.1080/10408347.2011.52172910.1080/10408347.2011.521729 ↗
9. Mürtz M (2005) Breath diagnostics using laser spectroscopy. Opt Photonics News 16:30–35. https://doi.org/10.1364/OPN.16.1.00003010.1364/OPN.16.1.000030 ↗
10. Lindinger W, Hansel A, Jordan A (1998) On-line monitoring of volatile organic compounds at pptv levels by means of proton-transfer-reaction mass spectrometry (PTR-MS) medical applications, food control and environmental research. Int J Mass Spectrom Ion Proc 173:191–241. https://doi.org/10.1016/S0168-1176(97)00281-410.1016/S0168-1176(97)00281-4 ↗
11. Warneke C, Kuczynski J, Hansel A, Jordan A, Vogel W, Lindinger W (1996) Proton transfer reaction mass spectrometry (PTR-MS): propanol in human breath. Int J Mass Spectrom Ion Proc 154:61–70. https://doi.org/10.1016/0168-1176(96)04369-810.1016/0168-1176(96)04369-8 ↗
12. Bajtarevic A, Ager C, Pienz M et al (2009) Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 9:1–16. https://doi.org/10.1186/1471-2407-9-34810.1186/1471-2407-9-348 ↗
13. Lindinger W, Hansel A (1997) Analysis of trace gases at ppb levels by proton transfer reaction mass spectrometry (PTR-MS). Plasma Sources Sci Technol 6:111–117. https://doi.org/10.1088/0963-0252/6/2/00410.1088/0963-0252/6/2/004 ↗
14. Wang Z, Wang C (2013) Is breath acetone a biomarker of diabetes? A historical review on breath acetone measurements. J Breath Res 7:037109. https://doi.org/10.1088/1752-7155/7/3/03710910.1088/1752-7155/7/3/037109 ↗
15. Donovan A (1996) Antoine Lavoisier: science, administration and revolution. Cambridge University Press, Cambridge
16. Pauling L, Robinson AB, Teranishi R, Cary P (1971) Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci 68:2374–2376. https://doi.org/10.1073/pnas.68.10.237410.1073/pnas.68.10.2374 ↗
17. Manolis A (1983) The diagnostic potential of breath analysis. Clin Chem 29:5–1510.1093/clinchem/29.1.5 ↗
18. Miekisch W, Schubert JK, Noeldge-Schomburg GF (2004) Diagnostic potential of breath analysis—focus on volatile organic compounds. Clin Chim Acta 347:25–39. https://doi.org/10.1016/j.cccn.2004.04.02310.1016/j.cccn.2004.04.023 ↗
19. Cao W, Duan Y (2006) Breath analysis: potential for clinical diagnosis and exposure assessment. Clin Chem 52:800–811. https://doi.org/10.1373/clinchem.2005.06354510.1373/clinchem.2005.063545 ↗
20. Amann A, Spanĕl P, Smith D (2007) Breath analysis: the approach towards clinical applications. Mini Rev Med Chem 7:115–129. https://doi.org/10.2174/13895570777980260610.2174/138955707779802606 ↗
21. Phillips M, Greenberg J (1991) Method for the collection and analysis of volatile compounds in the breath. J Chromatogr B Biomed Sci Appl 564:242–249. https://doi.org/10.1016/0378-4347(91)80086-R10.1016/0378-4347(91)80086-R ↗
22. Drabińska N, Flynn C, Ratcliffe N et al (2021) A literature survey of all volatiles from healthy human breath and bodily fluids: the human volatilome. J Breath Res 15:034001. https://doi.org/10.1088/1752-7163/abf1d010.1088/1752-7163/abf1d0 ↗
23. Shan B, Broza YY, Li W et al (2020) Multiplexed nanomaterial-based sensor array for detection of COVID-19 in exhaled breath. ACS Nano 14:12125–12132. https://doi.org/10.1021/acsnano.0c0565710.1021/acsnano.0c05657 ↗
24. Giovannini G, Haick H, Garoli D (2021) Detecting COVID-19 from breath: a game changer for a big challenge. ACS Sens 6:1408–1417. https://doi.org/10.1021/acssensors.1c0031210.1021/acssensors.1c00312 ↗
25. Grassin-Delyle S, Roquencourt C, Moine P et al (2021) Metabolomics of exhaled breath in critically ill COVID-19 patients: a pilot study. EBioMedicine 63:103154. https://doi.org/10.1016/j.ebiom.2020.10315410.1016/j.ebiom.2020.103154 ↗
26. BreFence (2021) BreFence TM GO COVID-19 Breath Test System Rapid Breath Test for COVID-19 Detection. Breathonix.
27. Loo K-Y, Thye AY-K, Law LN-S, Law JWF (2021) COVID-19: an updated situation from Singapore. Prog Microbes Mol Biol 4(1):a0000246. https://doi.org/10.36877/pmmb.a000024610.36877/pmmb.a0000246 ↗
28. Ng W (2023) Technological innovations in COVID-19 diagnostics in Singapore. Preprint 1:1–14. https://doi.org/10.20944/preprints202305.0369.v110.20944/preprints202305.0369.v1 ↗
29. Miekisch W, Herbig J, Schubert JK (2012) Data interpretation in breath biomarker research: pitfalls and directions. J Breath Res 6:036007. https://doi.org/10.1088/1752-7155/6/3/03600710.1088/1752-7155/6/3/036007 ↗
30. Pleil JD, Wallace MAG, Stiegel MA, Funk WE (2018) Human biomarker interpretation: the importance of intra-class correlation coefficients (ICC) and their calculations based on mixed models, ANOVA, and variance estimates. J Toxicol Environ Health Part B 21:161–18010.1080/10937404.2018.1490128 ↗
31. Cheng W-H, Lee W-J (1999) Technology development in breath microanalysis for clinical diagnosis. J Lab Clin Med 133:218–22810.1016/S0022-2143(99)90077-X ↗
32. Beauchamp J (2011) Inhaled today, not gone tomorrow: pharmacokinetics and environmental exposure of volatiles in exhaled breath. J Breath Res 5:03710310.1088/1752-7155/5/3/037103 ↗
33. Neerincx AH, Vijverberg SJ, Bos LD et al (2017) Breathomics from exhaled volatile organic compounds in pediatric asthma. Pediatr Pulmonol 52:1616–1627. https://doi.org/10.1002/ppul.2378510.1002/ppul.23785 ↗
34. Zhou X, Xue Z, Chen X et al (2020) Nanomaterial-based gas sensors used for breath diagnosis. J Mater Chem B 8:3231–3248. https://doi.org/10.1039/C9TB02518A10.1039/C9TB02518A ↗
35. Kim I-D (2017) How can nanotechnology be applied to sensors for breath analysis? Nanomed 12(22):2695–2697. https://doi.org/10.2217/nnm-2017-026910.2217/nnm-2017-0269 ↗
36. Zhang C-L, Yu S-H (2014) Nanoparticles meet electrospinning: recent advances and future prospects. Chem Soc Rev 43:4423–444810.1039/c3cs60426h ↗
37. Braun PX, Gmachl CF, Dweik RA (2012) Bridging the collaborative gap: realizing the clinical potential of breath analysis for disease diagnosis and monitoring–tutorial. IEEE Sens J 12:3258–327010.1109/JSEN.2012.2210403 ↗
38. Espinal L, Poster DL, Wong-Ng W, Allen AJ, Green ML (2013) Measurement, standards, and data needs for CO2 capture materials: a critical review. Environ Sci Technol 47(21):11960–1197510.1021/es402622q ↗
39. Phillips M, Altorki N, Austin JH et al (2007) Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark 3:95–109. https://doi.org/10.3233/CBM-2007-320410.3233/CBM-2007-3204 ↗
40. Bikov A, Paschalaki K, Logan-Sinclair R et al (2013) Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry. BMC Pulm Med 13:43(41-47). https://doi.org/10.1186/1471-2466-13-4310.1186/1471-2466-13-43 ↗
41. Amann A, de Lacy Costello B, Miekisch W et al (2014) The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva. J Breath Res 8:034001. https://doi.org/10.1088/1752-7155/8/3/03400110.1088/1752-7155/8/3/034001 ↗
42. Basanta M, Ibrahim B, Dockry R et al (2012) Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study. Respir Res 13:72. https://doi.org/10.1186/1465-9921-13-7210.1186/1465-9921-13-72 ↗
43. Basanta M, Jarvis RM, Xu Y et al (2010) Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst 135:315–320. https://doi.org/10.1039/B916374C10.1039/B916374C ↗
44. Ibrahim B, Basanta M, Cadden P et al (2011) Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax 66:804–809. https://doi.org/10.1136/thoraxjnl-2011-20084910.1136/thoraxjnl-2011-200849 ↗
45. Phillips M, Cataneo RN, Cheema T, Greenberg J (2004) Increased breath biomarkers of oxidative stress in diabetes mellitus. Clin Chim Acta 344:189–194. https://doi.org/10.1016/j.cccn.2004.02.02510.1016/j.cccn.2004.02.025 ↗
46. Del Río RF, O’Hara M, Holt A et al (2015) Volatile biomarkers in breath associated with liver cirrhosis—comparisons of pre-and post-liver transplant breath samples. EBioMedicine 2:1243–1250. https://doi.org/10.1016/j.ebiom.2015.07.02710.1016/j.ebiom.2015.07.027 ↗
47. Obermeier J, Trefz P, Happ J et al (2017) Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease. PLoS ONE 12:e0178745. https://doi.org/10.1371/journal.pone.017874510.1371/journal.pone.0178745 ↗
48. Cui L, Morris A, Huang L et al (2014) The microbiome and the lung. Ann Am Thorac Soc 11:S227–S232. https://doi.org/10.1513/AnnalsATS.201402-052PL10.1513/AnnalsATS.201402-052PL ↗
49. Fowler SJ, Basanta-Sanchez M, Xu Y, Goodacre R, Dark PM (2015) Surveillance for lower airway pathogens in mechanically ventilated patients by metabolomic analysis of exhaled breath: a case-control study. Thorax 70:320–325. https://doi.org/10.1136/thoraxjnl-2015-20696910.1136/thoraxjnl-2015-206969 ↗
50. Ahmed WM, Lawal O, Nijsen TM, Goodacre R, Fowler SJ (2017) Exhaled volatile organic compounds of infection: a systematic review. ACS Infect Dis 3:695–710. https://doi.org/10.1021/acsinfecdis.7b0008810.1021/acsinfecdis.7b00088 ↗
51. Davis MD, Montpetit A, Hunt J (2012) Exhaled breath condensate: an overview. Immunol Allergy Clin 32:363–375. https://doi.org/10.1016/j.iac.2012.06.01410.1016/j.iac.2012.06.014 ↗
52. Kubáň P, Foret F (2013) Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review Anal Chim Acta 805:1–18. https://doi.org/10.1016/j.aca.2013.07.04910.1016/j.aca.2013.07.049 ↗
53. Kabir E, Raza N, Kumar V et al (2019) Recent advances in nanomaterial-based human breath analytical technology for clinical diagnosis and the way forward. Chem 5:3020–305710.1016/j.chempr.2019.08.004 ↗
54. Davis MD, Fowler SJ, Montpetit AJ (2019) Exhaled breath testing–a tool for the clinician and researcher. Paediatr Respir Rev 29:37–41. https://doi.org/10.1016/j.prrv.2018.05.00210.1016/j.prrv.2018.05.002 ↗
55. Petsky HL, Kew KM, Chang AB (2016) Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev 1:CD011439. https://doi.org/10.1002/14651858.CD011439.pub210.1002/14651858.CD011439.pub2 ↗
56. Crofford OB, Mallard RE, Winton R, Rogers NL, Jackson JC, Keller U (1977) Acetone in breath and blood. Trans Am Clin Climatol 88:128–139
57. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012. https://doi.org/10.1056/NEJM19931230329270610.1056/NEJM199312303292706 ↗
58. Kharitonov S, Yates D, Barnes P (1995) Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 8:295–297. https://doi.org/10.1183/09031936.95.0802029510.1183/09031936.95.08020295 ↗
59. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ (1998) Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:998–1002. https://doi.org/10.1164/ajrccm.157.3.97-0500910.1164/ajrccm.157.3.97-05009 ↗
60. Barnes P, Kharitonov S (1996) Exhaled nitric oxide: a new lung function test. Thorax 51:233–237. https://doi.org/10.1136/thx.51.3.23310.1136/thx.51.3.233 ↗
61. Toombs CF, Insko MA, Wintner EA et al (2010) Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide. Br J Clin Pharmacol 69:626–636. https://doi.org/10.1111/j.1365-2125.2010.03636.x10.1111/j.1365-2125.2010.03636.x ↗
62. Rosenberg M, McCulloch CA (1992) Measurement of oral malodor: current methods and future prospects. J Periodontol 63:776–782. https://doi.org/10.1902/jop.1992.63.9.77610.1902/jop.1992.63.9.776 ↗
63. Suarez F, Furne J, Springfield J, Levitt MD (2000) Morning breath odor: influence of treatments on sulfur gases. J Dent Res 79:1773–1777. https://doi.org/10.1177/00220345000790100710.1177/002203450007901007 ↗
64. Rosenberg M (1996) Clinical assessment of bad breath: current concepts. J Am Dent Assoc (1939) 127:475–482. https://doi.org/10.14219/jada.archive.1996.023910.14219/jada.archive.1996.0239 ↗
65. Mazzone PJ, Hammel J, Dweik R et al (2007) Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax 62:565–568. https://doi.org/10.1136/thx.2006.07289210.1136/thx.2006.072892 ↗
66. Shawe-Taylor J, Cristianini N (2004) Kernel methods for pattern analysis. Cambridge University Press, Cambridge10.1017/CBO9780511809682 ↗
67. Paredi P, Kharitonov SA, Leak D, Ward S, Cramer D, Barnes PJ (2000) Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162:369–373. https://doi.org/10.1164/ajrccm.162.2.990902510.1164/ajrccm.162.2.9909025 ↗
68. Knutson MD, Handelman GJ, Viteri FE (2000) Methods for measuring ethane and pentane in expired air from rats and humans. Free Radic Biol Med 28:514–519. https://doi.org/10.1016/S0891-5849(99)00230-010.1016/S0891-5849(99)00230-0 ↗
69. Gasbarrini A, Corazza G, Gasbarrini G et al (2009) Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 29:1–4910.1111/j.1365-2036.2009.03951.x ↗
70. Kerlin P, Wong L (1988) Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 95:982–988. https://doi.org/10.1016/0016-5085(88)90173-410.1016/0016-5085(88)90173-4 ↗
71. Essiet IO (2013) Diagnosis of kidney failure by analysis of the concentration of ammonia in exhaled human breath. J Emerg Trends Eng Appl Sci 4:859–862
72. Bass NM, Mullen KD, Sanyal A et al (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362:1071–1081. https://doi.org/10.1056/NEJMoa090789310.1056/NEJMoa0907893 ↗
73. Amano A, Yoshida Y, Oho T, Koga T (2002) Monitoring ammonia to assess halitosis. Oral Surg Oral Med Oral Pathol Oral Radiol 94:692–696. https://doi.org/10.1067/moe.2002.12691110.1067/moe.2002.126911 ↗
74. MacGregor G, Ellis S, Andrews J et al (2005) Breath condensate ammonium is lower in children with chronic asthma. Eur Respir J 26:271–276. https://doi.org/10.1183/09031936.05.0010620410.1183/09031936.05.00106204 ↗
75. O’Brien PJ, Siraki AG, Shangari N (2005) Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit Rev Toxicol 35:609–662. https://doi.org/10.1080/1040844059100218310.1080/10408440591002183 ↗
76. Lucidi P, Porcellati F, Cioli P et al (2020) Greater suppression of glucagon, lipolysis, and ketogenesis with insulin glargine U300 as compared with glargine U100 in type 1 diabetes mellitus. Diabetes Technol Ther 22:57–61. https://doi.org/10.1089/dia.2019.023110.1089/dia.2019.0231 ↗
77. Laffel L (1999) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev 15:412–426. https://doi.org/10.1002/(SICI)1520-7560(199911/12)15:6%3c412::AID-DMRR72%3e3.0.CO;2-810.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8 ↗
78. Dhillon KK, Gupta S (2022) Biochemistry, ketogenesis. In: StatPearls [Internet]. StatPearls Publishing
79. Turner C, Španěl P, Smith D (2006) A longitudinal study of ammonia, acetone and propanol in the exhaled breath of 30 subjects using selected ion flow tube mass spectrometry. SIFT-MS Physiological Measurement 27:321–337. https://doi.org/10.1088/0967-3334/27/4/00110.1088/0967-3334/27/4/001 ↗
80. Königstein K, Abegg S, Schorn AN et al (2020) Breath acetone change during aerobic exercise is moderated by cardiorespiratory fitness. J Breath Res 15:016006. https://doi.org/10.1088/1752-7163/abba6c10.1088/1752-7163/abba6c ↗
81. Musa-Veloso K, Likhodii SS, Rarama E et al (2006) Breath acetone predicts plasma ketone bodies in children with epilepsy on a ketogenic diet. Nutrition 22:1–810.1016/j.nut.2005.04.008 ↗
82. Toyooka T, Hiyama S, Yamada Y (2013) A prototype portable breath acetone analyzer for monitoring fat loss. J. Breath Res 7:036005. https://doi.org/10.1088/1752-7155/7/3/03600510.1088/1752-7155/7/3/036005 ↗
83. Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. The FASEB J 6:3051–3064. https://doi.org/10.1096/fasebj.6.12.138169110.1096/fasebj.6.12.1381691 ↗
84. Pavord ID, Shaw DE, Gibson PG, Taylor DR (2008) Inflammometry to assess airway diseases. The Lancet 372:1017–1019. https://doi.org/10.1016/S0140-6736(08)61421-X10.1016/S0140-6736(08)61421-X ↗
85. Loewenthal L, Menzies-Gow A (2022) Seminars in respiratory and critical care medicine. Thieme Medical Publishers Inc, New York 43(05):635–645. https://doi.org/10.1055/s-0042-174329010.1055/s-0042-1743290 ↗
86. Dweik RA, Boggs PB, Erzurum SC et al (2011) An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 184:602–61510.1164/rccm.9120-11ST ↗
87. Schiller B, Hammer J, Barben J, Trachsel D (2009) Comparability of a hand-held nitric oxide analyser with online and offline chemiluminescence-based nitric oxide measurement. Pediatr Allergy Immunol 20:679–68510.1111/j.1399-3038.2009.00853.x ↗
88. Gadalla MM, Snyder SH (2010) Hydrogen sulfide as a gasotransmitter. J Neurochem 113:14–26. https://doi.org/10.1111/j.1471-4159.2010.06580.x10.1111/j.1471-4159.2010.06580.x ↗
89. Wang J-F, Li Y, Song J-N, Pang H-G (2014) Role of hydrogen sulfide in secondary neuronal injury. Neurochem Int 64:37–47. https://doi.org/10.1016/j.neuint.2013.11.00210.1016/j.neuint.2013.11.002 ↗
90. Wang R (2002) Two’s company, three’s a crowd: can H2S be the third endogenous gaseous transmitter? The FASEB J 16:1792–1798. https://doi.org/10.1096/fj.02-0211hyp10.1096/fj.02-0211hyp ↗
91. Łowicka E, Bełtowski J (2007) Hydrogen sulfide (H2S)-the third gas of interest for pharmacologists. Pharmacol Rep PR 59:4–24.
92. Kimura H (2011) Hydrogen sulfide: its production and functions. Exp Physiol 96:833–835. https://doi.org/10.1113/expphysiol.2011.05745510.1113/expphysiol.2011.057455 ↗
93. Riely CA, Cohen G, Lieberman M (1974) Ethane evolution: a new index of lipid peroxidation. Sci 183:208–210. https://doi.org/10.1126/science.183.4121.20810.1126/science.183.4121.208 ↗
94. Wendland BE, Aghdassi E, Tam C et al (2001) Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am J Clin Nutr 74:259–264. https://doi.org/10.1093/ajcn/74.2.25910.1093/ajcn/74.2.259 ↗
95. Olopade CO, Christon JA, Zakkar M et al (1997) Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 111:1500–1504. https://doi.org/10.1378/chest.111.6.150010.1378/chest.111.6.1500 ↗
96. Mendis S, Sobotka PA, Leia FL, Euler DE (1995) Breath pentane and plasma lipid peroxides in ischemic heart disease. Free Radic Biol Med 19:679–684. https://doi.org/10.1016/0891-5849(95)00053-Z10.1016/0891-5849(95)00053-Z ↗
97. Makableh Y, Athamneh T, Ajlouni M, Hijazi S, Alnaimi A (2023) Enhanced response and selective gold nanoparticles/carbon nanotubes biosensor for the early detection of HER2 biomarker. Sens Actuators Rep 5:100158. https://doi.org/10.1016/j.snr.2023.10015810.1016/j.snr.2023.100158 ↗
98. Breiman L (2001) Random forests. Mach Learn 45:5–32. https://doi.org/10.1023/A:101093340432410.1023/A:1010933404324 ↗
99. Efron B (1992) Bootstrap methods: another look at the jackknife. In: Breakthroughs in statistics: Methodology and distribution (pp. 569–593). Springer, New York
100. Kurada S, Alkhouri N, Fiocchi C, Dweik R, Rieder F (2015) breath analysis in inflammatory bowel diseases. Aliment Pharmacol Ther 41:329–341. https://doi.org/10.1111/apt.1305010.1111/apt.13050 ↗